Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1338-1342

  Nguyen, Geoffrey C ^a,b,c   Leung, Wesley ^a   Weizman, Adam V ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (Canada)

Author keywords

Crohn's disease; hospitalization; inflammatory bowel disease; ulcerative colitis; vancomycin resistant Enterococcus; VRE

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ENTERITIS; ENTEROCOCCAL INFECTION; FEMALE; HOSPITAL ADMISSION; HOSPITAL CHARGE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; UNITED STATES; VANCOMYCIN;

EID: 79955792532     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21519     Document Type: Article

References (26)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29: 996-1011.
2. Ramsey AM, Zilberberg MD., Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009; 30: 184-186.
3. DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005; 41: 327-333. (Pubitemid 41022109)
4. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993; 16: 750-755. (Pubitemid 23157976)
5. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994; 38: 1363-1367. (Pubitemid 24170720)
6. Rubin LG, Tucci V, Cercenado E, et al. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992; 13: 700-705.
7. Zirakzadeh A, Patel R,. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc. 2006; 81: 529-536.
8. Calfee DP, Giannetta ET, Durbin LJ, et al. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis. 2003; 37: 326-332. (Pubitemid 36976488)
9. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001; 344: 1427-1433. (Pubitemid 32402099)
10. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008; 103: 1443-1450. (Pubitemid 351813903)
11. Nguyen GC, Patel H, Chong RY., Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients. Am J Gastroenterol. 2010; 105: 371-377.
12. Whalen D, Houchens R, Elixhauser A,. 2002 HCUP Nationwide Inpatient Sample (NIS) Comparison Report. U.S. Agency for Healthcare Research and Quality; 2005: 1-89.
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139. (Pubitemid 41587600)
14. Deyo RA, Cherkin DC, Ciol MA., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619.
15. Quan H, Parsons GA, Ghali WA., Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care. 2002; 40: 675-685.
16. Quan H, Parsons GA, Ghali WA., Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care. 2004; 42: 801-809.
17. Ananthakrishnan AN, McGinley EL, Binion DG., Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008; 57: 205-210. (Pubitemid 351158048)
18. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 345-351. (Pubitemid 46401531)
19. Butler AM, Olsen MA, Merz LR, et al. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol. 2010; 31: 28-35.
20. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med. 2001; 135: 175-183. (Pubitemid 32738311)
21. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000; 343: 1925-1932. (Pubitemid 32064786)
22. Grimes DA, Schulz KF., Bias and causal associations in observational research. Lancet. 2002; 359: 248-252. (Pubitemid 34113828)
23. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007; 28: 249-260. (Pubitemid 46480722)
24. Hachem R, Raad I., Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2002; 23: 43-44. (Pubitemid 34157777)
25. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol. 1999; 20: 106-109.
26. Puzniak LA, Leet T, Mayfield J, et al. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2002; 35: 18-25. (Pubitemid 34666855)